Sun M-Y, Li L-P
Department of Clinical Laboratory, Jining No. 1 People's Hospital, Jining, China.
Eur Rev Med Pharmacol Sci. 2021 Jan;25(1):1. doi: 10.26355/eurrev_202101_24298.
The article "MiR-140-5p targets BCL2L1 to promote cardiomyocyte apoptosis, by M.-Y. Sun, L.-P. Li, published in Eur Rev Med Pharmacol Sci 2020; 24 (11): 6311-6322-DOI: 10.26355/eurrev_202006_21529-PMID: 32572928" has been withdrawn from the authors. They stated that "they are still working on this study" and that "they found some current experimental results which are inconsistent with the previous ones. Moreover, they added that "these inconsistent results may be caused by the contamination of the previous experimental cell lines". The Publisher apologizes for any inconvenience this may cause. https://www.europeanreview.org/article/21529.
由孙美瑶、李立平发表于《欧洲医学与药理学评论》2020年第24卷第11期,第6311 - 6322页,DOI: 10.26355/eurrev_202006_21529,PMID: 32572928的文章《MiR - 140 - 5p靶向BCL2L1促进心肌细胞凋亡》已被作者撤回。他们表示“仍在进行这项研究”,且“发现当前一些实验结果与之前的结果不一致。此外,他们补充说“这些不一致的结果可能是由之前实验细胞系的污染导致的”。出版方就此事可能造成的不便表示歉意。https://www.europeanreview.org/article/21529